Ameritas Investment Partners’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-5,064
| Closed | -$344K | – | 3083 |
|
|
2022
Q3 | $344K | Buy |
5,064
+371
| +8% | +$20.5K | 0.02% | 846 |
|
|
2022
Q2 | $149K | Hold |
4,693
| – | – | 0.01% | 1239 |
|
|
2022
Q1 | $163K | Hold |
4,693
| – | – | 0.01% | 1312 |
|
|
2021
Q4 | $137K | Hold |
4,693
| – | – | ﹤0.01% | 1496 |
|
|
2021
Q3 | $120K | Hold |
4,693
| – | – | ﹤0.01% | 1571 |
|
|
2021
Q2 | $164K | Buy |
+4,693
| New | +$183K | 0.01% | 1402 |
|
|
2020
Q2 | – | Sell |
-5,178
| Closed | -$265K | – | 3177 |
|
|
2020
Q1 | $265K | Buy |
5,178
+116
| +2% | +$7.77K | 0.02% | 823 |
|
|
2019
Q4 | $402K | Buy |
5,062
+245
| +5% | +$14.5K | 0.02% | 807 |
|
|
2019
Q3 | $234K | Buy |
4,817
+191
| +4% | +$9.95K | 0.01% | 974 |
|
|
2019
Q2 | $243K | Buy |
4,626
+211
| +5% | +$12.1K | 0.01% | 968 |
|
|
2019
Q1 | $234K | Buy |
4,415
+364
| +9% | +$17.9K | 0.01% | 968 |
|
|
2018
Q4 | $166K | Hold |
4,051
| – | – | 0.01% | 1067 |
|
|
2018
Q3 | $154K | Hold |
4,051
| – | – | 0.01% | 1269 |
|
|
2018
Q2 | $183K | Buy |
4,051
+810
| +25% | +$36.9K | 0.01% | 1118 |
|
|
2018
Q1 | $157K | Hold |
3,241
| – | – | 0.01% | 1213 |
|
|
2017
Q4 | $128K | Hold |
3,241
| – | – | 0.01% | 1357 |
|
|
2017
Q3 | $98K | Hold |
3,241
| – | – | ﹤0.01% | 1479 |
|
|
2017
Q2 | $89K | Buy |
3,241
+1,538
| +90% | +$45.8K | ﹤0.01% | 1531 |
|
|
2017
Q1 | $63K | Buy |
+1,703
| New | +$42.9K | ﹤0.01% | 1696 |
|
Other funds holding GBT
Ameritas Investment Partners's GBT Position: Q4 2022 in Review
Ameritas Investment Partners sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 5,064 shares — an estimated $344K sold.
Ameritas Investment Partners first reported a position in GBT in Q1 2017 and held it in 19 quarters. The position peaked at $402K in Q4 2019. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- Ameritas Investment Partners reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- Ameritas Investment Partners sold 5,064 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $344K.
- Ameritas Investment Partners first reported a position in Global Blood Therapeutics, Inc. in Q1 2017 and held it in 19 quarters.
- Ameritas Investment Partners's Global Blood Therapeutics, Inc. position peaked at $402K in Q4 2019.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on Ameritas Investment Partners's 13F filing for Q4 2022, filed 13 Feb 2023.